Ligand and Structure-Based Pharmacophore Modeling for the Discovery of Potential Human HNMT Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|9|1|17-29

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.9, Iss.1, 2012-01, pp. : 17-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based Discovery of PDEs Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-04 ,pp. : 917-933

Bentham Science Publishers

Access to resources Recommend Favorite

Target Structure-based Modeling of the Glutamate Transporter Pharmacophore

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 5, 2006-01 ,pp. : 293-297

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel BACE1 Inhibitors by Combination of Pharmacophore Modeling, Structure-Based Design and In Vitro Assay

By  

Current Computer - Aided Drug Design, Vol. 12, Iss. 1, 2016-03 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

By Matthews Thomas P   Jones Alan M   Collins Ian  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 6, 2013-10 ,pp. : 621-640

Informa Healthcare

Access to resources Recommend Favorite